Determination of human immunodeficiency virus type 1 subtypes by a rapid method useful for the routine diagnostic laboratory
- PMID: 11527821
- PMCID: PMC96189
- DOI: 10.1128/CDLI.8.5.1018-1020.2001
Determination of human immunodeficiency virus type 1 subtypes by a rapid method useful for the routine diagnostic laboratory
Abstract
The existence of human immunodeficiency virus type 1 (HIV-1) subtypes has many important implications for the global evolution of HIV and for the evaluation of pathogenicity, transmissibility, and candidate HIV vaccines. The aim of this study was to establish a rapid method for determination of HIV-1 subtypes useful for a routine diagnostic laboratory and to investigate the distribution of HIV-1 subtypes in Austrian patients. Samples were tested by a subtyping method based on a 1.3-kb sequence of the polymerase gene generated by a commercially available drug resistance assay. The generated sequence was subtyped by means of an HIV sequence database. Results of 74 routine samples revealed subtype B (71.6%) as the predominant subtype, followed by subtype A (13.5%) and subtype C (6.8%). Subtypes E, F, G, and AE (CM240) were also detected. This subtyping method was found to be very easy to handle, rapid, and inexpensive and has proved suitable for high-throughput routine diagnostic laboratories. The specific polymerase gene sequence, however, must be existent.
Figures
Similar articles
-
High specificity of V3 serotyping among human immunodeficiency virus type-1 subtype C infected patients with varying disease status and viral phenotype.J Med Virol. 2006 Oct;78(10):1262-8. doi: 10.1002/jmv.20690. J Med Virol. 2006. PMID: 16927278
-
Optimization of a genotypic assay applicable to all human immunodeficiency virus type 1 protease and reverse transcriptase subtypes.J Virol Methods. 2005 Sep;128(1-2):47-53. doi: 10.1016/j.jviromet.2005.04.001. J Virol Methods. 2005. PMID: 15871907
-
Performance of two commercially available sequence-based HIV-1 genotyping systems for the detection of drug resistance against HIV type 1 group M subtypes.J Med Virol. 2003 Jul;70(3):337-42. doi: 10.1002/jmv.10401. J Med Virol. 2003. PMID: 12766994
-
Determination of HIV-1 subtypes (A-D, F, G, CRF01_AE) by PCR in the transmembrane region (gp41) with novel primers.J Med Virol. 2005 May;76(1):16-23. doi: 10.1002/jmv.20318. J Med Virol. 2005. PMID: 15778948
-
Genotypic resistance tests for the management of the HIV-infected patient with non-B viral isolates.Scand J Infect Dis Suppl. 2003;106:75-8. Scand J Infect Dis Suppl. 2003. PMID: 15000590 Review.
Cited by
-
Evaluation of automated sample preparation and quantitative PCR LCx assay for determination of human immunodeficiency virus type 1 RNA.J Clin Microbiol. 2004 Apr;42(4):1439-43. doi: 10.1128/JCM.42.4.1439-1443.2004. J Clin Microbiol. 2004. PMID: 15070986 Free PMC article.
-
Subtype and genotypic resistance analysis of HIV-1 infected patients in Austria.Wien Klin Wochenschr. 2007;119(5-6):181-5. doi: 10.1007/s00508-006-0745-4. Wien Klin Wochenschr. 2007. PMID: 17427022
-
Correlation between resistance profile and immunosuppression in heavily treated HIV-1 infected Romanian patients.Rom Biotechnol Lett. 2011 Aug;16(4):6439-6449. Rom Biotechnol Lett. 2011. PMID: 22180722 Free PMC article.
References
-
- Adwan G, Papa A, Kouidou S, Alexiou S, Ialissiovas N, Itoutsos I, Kiosses V, Antoniadis A. Genetic heterogeneity of HIV-1 in Greece. Microbes Infect. 2000;2:353–357. - PubMed
-
- Alaeus A, Leitner T, Lidman K, Albert J. Most HIV-1 genetic subtypes have entered Sweden. AIDS. 1997;11:199–202. - PubMed
-
- Barlow K L, Tosswill J H, Clewley J P. Analysis and genotyping of PCR products of the Amplicor HIV-1 kit. J Virol Methods. 1995;52:65–74. - PubMed
-
- Carr J K, Salminen M O, Albert J, Sanders-Buell E, Gotte D, Birx D L, McCutchan F E. Full genome sequences of human immunodeficiency virus type 1 subtypes G and A/G intersubtype recombinants. Virology. 1998;247:22–31. - PubMed
-
- Clevenbergh P, Durant J, Halfon P, del Giudice P, Mondain V, Montagne N, Schapiro J M, Boucher C A, Dellamonica P. Persisting long-term benefit of genotype-guided treatment for HIV-infected patients failing HAART. The Viradapt Study: week 48 follow-up. Antivir Ther. 2000;5:65–70. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical